Science and Technology Innovation Program
September 24, 2002 // 7:00am — 8:15pm
May 20, 2002 // 12:00am
January 17, 2002 // 11:00pm
Science, technology and innovation are keys to addressing a host of challenges our nation will face in the coming years. Former presidential science advisors address this in an article calling for the president-elect to appoint his advisor quickly.
Published by the Commons Lab, "New Visions in Citizen Science" showcases seventeen case studies that offer a mosaic view of federally-sponsored citizen science and open innovation projects, from in-the-field data collection to online games for collective problem-solving. This report offers a sampling of different models that support public contribution, potential challenges, and positive impacts that projects can have on scientific literacy, research, management, and public policy.
The Center's Foresight and Governance Project seminar "Nanotechnology: Real Revenues Today and Impacts on the U.S. Economy” featured four leading nanotechnology firms with current products on the market – Nano-tex, Hyperion Catalysis, Inmat, and Optiva - and a renowned panel with Senator Ron Wyden of Oregon, Phil Bond, Undersecretary of Technology at Commerce, and Mark Modzelewski of the NanoBusiness Alliance. Video of Seminar (RealPlayer)
A new report defines the criteria for a new technology assessment function in the United States, emphasizing the need to incorporate citizen-participation methods to complement expert analysis.
Internationally-recognized environmental scientist Barbara Karn has joined the Project on Emerging Nanotechnologies. Dr. Karn will focus on innovative ways to apply the principles of "green" chemistry and "green" engineering to nanotechnology.
Today’s bio-economy, where info-, nano-, and biotechnology converge, has the potential to yield great advances in all sectors, including medicine and energy, by using advanced modes of manufacturing at an atomic scale while achieving reproducible results. This creative convergence sounds exciting, but scientific advances and technological innovation do not come without some risks. Policymakers need to adopt a critical perspective on governance approaches regarding the bio-economy, keeping in mind how it affects our intricate sociotechnical system, our regulatory cultures, and the evolving relationships between researchers, funders, industry and the public.